162
report
Scaling Comprehensive Dementia-Care Models
Despite scientific progress over the past 25 years, dementia remains one of the toughest health-car
e challenges.
+ Read More
report
Neurotechnology: A Giving Smarter Guide
When most people think about advances in medicine, drug development is the first thing that comes t
o mind. However, technology and devices are proving to be valuable options for treating intractable illnesses.
+ Read More
report
Creating a Nonprofit Marketplace for Shelved Drugs: Lessons from a Pilot Project
Many promising medicines, despite strong safety data and pharmaceutical characteristics, are discon
tinued by drug companies for nonscientific reasons, including strategic, organizational, and financial considerations.
+ Read More
report
Alzheimer's Disease - A Giving Smarter Guide
Alzheimer’s disease is increasingly in the spotlight after a number of high-profile clinical trial
failures—an alarming trend as an estimated 5.5 million adult Americans live with this disease, which disproportionally affects the aged population.
+ Read More
report
Hedging Pipeline Risk in Pharma: FDA Swaps and Annuities
The cost of capital to conduct medical R&D is high because investors must be compensated with s
ignificant returns to offset the risky and long drug-development process.
+ Read More
report
Alzheimer's Disease: A Giving Smarter Guide to Accelerate Development of New Therapies
The need is staggering. Alzheimer's disease is the sixth leading cause of death in the United State
s and currently, more than 5.5 million Americans are living with this disease for which there is yet no cure yet.
+ Read More
report
Misophonia - A Giving Smarter Guide
report
Reducing the Cost and Risk of Dementia
Increased longevity is perhaps one of the greatest success stories of our modern public health syst
em. But along with this success comes one of our greatest challenges to healthy longevity.
+ Read More
report
The Future of Aging
In this collection of essays from the Center for the Future of Aging, experts identify challenges a
nd opportunities in realizing the potential of healthy, productive and purposeful aging.
+ Read More
report
Nonprofits: A Growing Force in Drug Development
Shepherding a drug from discovery to the market is a complex process that involves many actors.
report
Patient-Focused Drug Development Meetings: Smart Practices from Community Leaders
FasterCures, a center of the Milken Institute, designed this guide for patient advocacy organizatio
ns that are interested in hosting, or are currently planning, an externally led patient-focused drug development (PFDD)
+ Read More
report
GBM: Giving Smarter
Glioblastoma Multiforme (GBM) is an aggressive malignant brain tumor involving glial cells of the b
rain. At the time of this report, nearly 15,000 people were diagnosed with GBM each year in the United States and Europe.
+ Read More